Bulls v Bears, page-59

@AmbiGuity debating rather then arguing. I would rather be wrong on the forums then wrong on the market.

By fudge factor i just meant they would would work out what they think it is then add on more to be safe. That isn't inflammatory at all. Saying they are going to do a CR 2 months after they just raised $25mil capital and right after some other companies have done a CR and it has dropped their SP so what you said may worry some people which could be considered inflammatory.


link for filing statement is. https://www.newcannabisventures.com/wp-content/uploads/Harvest-One-Filing-Statement-03-30-2017.pdf

If you really care that much about how the money is broken down for budgeted wage and an itemised breakdown of all costs you can look at the combined financials of UG and satipharm for 2016 and try extrapolate the data yourself. Harvest is a shell that was emptied out and so i dont think their financial history is relevant. It looks to me like they would have to double wages paid and expenses (separate from the expansion) over the year to even use the money available and that is with no additional revenue. Or you can just wait until they sort their stuff out and update their website/investor presentation/announcement.

The amount they raised went up from a planned 15 to 25mil but the expansion plan stayed at 9mil so they have more money then they originally planned. As for the budget being used up, which would actually take 12 months, my point which i didn't bother explaining more because i thought it would be obvious is that there are other options besides a CR.

They could borrow the money from a bank or similar like lots of businesses do. MMJ could put some money back into hvst since they haven't said what they are doing with the 3.9 million they are getting from the deal plus other money they have possibly 5.2mil according to something i read. MMJ directors still run satipharm and UG they just have less shares now. HVST is just another shell company to list on TSX.

"Where is the revenue going to be generated to stave off insolvency?" Yes UG is going to take a bit to get to get started on the growing side but like i said and Dr D showed the maths on with current capacity of 1000kg/yr being $8mil (not licenced for more then 100kg yet) and then the ADDED 7500kg/yr ("PF total capacity: 8,500 kg/y; Capex: $9M") being 60mil from phase 1 expansion.

Satipharm will start selling CBD gel pill to 12+ countries in the EU plus Canada and Australia through HL pharma plus roll out of new products. Cant find any actual useful numbers though.

Phytotech might also do some thing useful like provide research data or a product.

If a CR for MMJ or HVST happens in 12 months and i am still holding i wont care because the SP will be at least double and i think even higher especially HVST.

You can worry about phase 2 in 12 months when the company has actually said what they are going to do.